157 related articles for article (PubMed ID: 31665802)
1. Venous Thromboembolism Prophylaxis: Safe, but Still Provocative?
Pelargos PE; Dunn IF
Thromb Haemost; 2019 Nov; 119(11):1716-1718. PubMed ID: 31665802
[No Abstract] [Full Text] [Related]
2. Safety and Effectiveness of Enoxaparin as Venous Thromboembolism Prophylaxis after Gastric Cancer Surgery in Japanese Patients.
Yanagita T; Kusanagi H
Am Surg; 2016 Dec; 82(12):1232-1237. PubMed ID: 28234190
[TBL] [Abstract][Full Text] [Related]
3. Systematic review of prophylaxis for venous thromboembolism after knee arthroplasty: enoxaparin versus rivaroxaban.
Rodarte RRP; Guimarães JAM; Franco JS; Fonseca L; Nascimento V; Aramburu JPG; Barretto JM
Rev Col Bras Cir; 2019 May; 46(2):e2075. PubMed ID: 31090863
[TBL] [Abstract][Full Text] [Related]
4. Comparative Effectiveness and Safety of Drug Prophylaxis for Prevention of Venous Thromboembolism After Total Knee Arthroplasty.
Cafri G; Paxton EW; Chen Y; Cheetham CT; Gould MK; Sluggett J; Bini SA; Khatod M
J Arthroplasty; 2017 Nov; 32(11):3524-3528.e1. PubMed ID: 28634095
[TBL] [Abstract][Full Text] [Related]
5. Late venous thromboembolism prophylaxis after craniotomy in acute traumatic brain injury.
Daley MJ; Ali S; Brown CV
Am Surg; 2015 Feb; 81(2):207-11. PubMed ID: 25642886
[TBL] [Abstract][Full Text] [Related]
6. Retrospective comparison of low molecular weight heparin vs. warfarin vs. oral Xa inhibitors for the prevention of recurrent venous thromboembolism in oncology patients: The Re-CLOT study.
Alzghari SK; Seago SE; Garza JE; Hashimie YF; Baty KA; Evans MF; Shaver C; Herrington JD
J Oncol Pharm Pract; 2018 Oct; 24(7):494-500. PubMed ID: 28714376
[TBL] [Abstract][Full Text] [Related]
7. Apixaban or enoxaparin for thromboprophylaxis.
Gómez-Outes A; Suárez-Gea ML; Pozo-Hernández C
N Engl J Med; 2009 Nov; 361(21):2100-1; author reply 2101. PubMed ID: 19923583
[No Abstract] [Full Text] [Related]
8. Prevention of Postoperative Venous Thromboembolism in Thoracic Surgical Patients: Implementation and Evaluation of a Caprini Risk Assessment Protocol.
Hachey KJ; Sterbling H; Choi DS; Pinjic E; Hewes PD; Munoz J; McAneny D; Tripodis Y; Fernando HC; Litle VR
J Am Coll Surg; 2016 Jun; 222(6):1019-27. PubMed ID: 26775163
[TBL] [Abstract][Full Text] [Related]
9. Edoxaban versus warfarin for venous thromboembolism.
Haft JI
N Engl J Med; 2014 Jan; 370(1):80. PubMed ID: 24382070
[No Abstract] [Full Text] [Related]
10. Edoxaban versus warfarin for venous thromboembolism.
Büller HR
N Engl J Med; 2014 Jan; 370(1):80-1. PubMed ID: 24382069
[No Abstract] [Full Text] [Related]
11. Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin.
Fitzgerald RH; Spiro TE; Trowbridge AA; Gardiner GA; Whitsett TL; O'Connell MB; Ohar JA; Young TR;
J Bone Joint Surg Am; 2001 Jun; 83(6):900-6. PubMed ID: 11407799
[TBL] [Abstract][Full Text] [Related]
12. Dabigatran versus enoxaparin after total hip replacement.
Martins HS; Scalabrini-Neto A; Velasco IT
Lancet; 2007 Dec; 370(9604):2002-3; author reply 2003-4. PubMed ID: 18083399
[No Abstract] [Full Text] [Related]
13. Variability is the standard: the management of venous thromboembolic disease following trauma.
Bandle J; Shackford SR; Sise CB; Knudson MM;
J Trauma Acute Care Surg; 2014 Jan; 76(1):213-6. PubMed ID: 24368382
[No Abstract] [Full Text] [Related]
14. Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Primary Hip and Knee Arthroplasty as Reported by American Board of Orthopedic Surgery Part II Candidates.
Runner RP; Gottschalk MB; Staley CA; Pour AE; Roberson JR
J Arthroplasty; 2019 Apr; 34(4):729-734. PubMed ID: 30685257
[TBL] [Abstract][Full Text] [Related]
15. Early Response to Warfarin Initiation and the Risk of Venous Thromboembolism After Total Joint Arthroplasty.
Edelstein AI; Terzaghi C; Nudelman B; Qin C; Kwasny M; Manning DW
J Am Acad Orthop Surg; 2018 Feb; 26(4):e90-e97. PubMed ID: 29351137
[TBL] [Abstract][Full Text] [Related]
16. Venous thromboembolism prophylaxis in brain tumor patients undergoing craniotomy: a meta-analysis.
Alshehri N; Cote DJ; Hulou MM; Alghamdi A; Alshahrani A; Mekary RA; Smith TR
J Neurooncol; 2016 Dec; 130(3):561-570. PubMed ID: 27591773
[TBL] [Abstract][Full Text] [Related]
17. Underutilization of anticoagulant for venous thromboembolism prophylaxis in three hospitals in Jakarta.
Atmakusuma TD; Tambunan KL; Sukrisman L; Effendi S; Rachman A; Setiawati A; Rinaldi I; Mulansari NA; Rajabto W; Nasution SA; Muhadi ; Aninditha T; Sedono R; Sugiarto A; Pitoyo CW; Paramitha D; Astoro NW; Nasution IR
Acta Med Indones; 2015 Apr; 47(2):136-45. PubMed ID: 26260556
[TBL] [Abstract][Full Text] [Related]
18. Prophylaxis of Postoperative Venous Thromboembolism Using Enoxaparin After Esophagectomy: A Prospective Observational Study of Effectiveness and Safety.
Yoshida N; Baba Y; Miyamoto Y; Iwatsuki M; Hiyoshi Y; Ishimoto T; Imamura Y; Watanabe M; Baba H
Ann Surg Oncol; 2018 Aug; 25(8):2434-2440. PubMed ID: 29876696
[TBL] [Abstract][Full Text] [Related]
19. Utility of anti-factor Xa monitoring in surgical patients receiving prophylactic doses of enoxaparin for venous thromboembolism prophylaxis.
Pannucci CJ; Prazak AM; Scheefer M
Am J Surg; 2017 Jun; 213(6):1143-1152. PubMed ID: 27692434
[TBL] [Abstract][Full Text] [Related]
20. Extended travel after hip arthroplasty surgery. Is it safe?
Ball ST; Pinsorsnak P; Amstutz HC; Schmalzried TP
J Arthroplasty; 2007 Sep; 22(6 Suppl 2):29-32. PubMed ID: 17823011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
